Cue Biopharma downsizes to focus on autoimmune pipeline
Cue Biopharma has instituted strategic restructuring measures with a plan to focus on autoimmune programs and carry out a workforce…
Cue Biopharma has instituted strategic restructuring measures with a plan to focus on autoimmune programs and carry out a workforce…
European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve…
Neuspera Medical has announced that its implantable sacral neuromodulation (SNM) system for treating urinary urge incontinence has met the primary…
Chinese pharmaceutical company Gan & Lee Pharmaceuticals has released Phase IIb data for its glucagon-like peptide 1 (GLP-1) receptor agonist…
French device company EDAP TMS has released interim data from the Phase III trial of its robotic high-intensity focused ultrasound…
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
Bayer is set to pursue a label expansion for Nubeqa (darolutamide) in a distinct subgroup of prostate cancer patients—those with…
Massachusetts, US-based cardiology biotech Cardurion Pharmaceuticals has raised $260m in Series B financing to advance its drug pipeline. The proceeds…
Hyperfine has teased results showing the utility of its portable magnetic resonance brain imaging (MRI), Swoop system for assessing stroke…
FluGen has published the results of a Phase I trial showing that its intranasal flu vaccine, M2SR, when used in…